Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website release update rather than any change to the clinical trial study details.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check80 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no study data, eligibility criteria, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 in the page header, indicating a backend/template change. No substantive study content, eligibility criteria, or results are affected by this update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.